Cafepharma Today

December 12 2024 - Industry M&A volume declined 8% this year compared to '23
Industry M&A volume declined 8% this year compared to '23
Pfizer's Ibrance improves survival in new breast cancer indication
Lynparza boosts long-term survival in early breast cancer
Trump says "big discussion" over childhood vaccine programs is coming
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

BDSI gets good news on drug, though approval is delayed
Bizjournals.com
Thursday, August 28, 2008 - 10:54am
tags:
J&J to appeal Razadyne patent ruling
Marketwatch
Thursday, August 28, 2008 - 10:53am
tags:
Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE
Yahoo/AP
Thursday, August 28, 2008 - 9:21am
tags:
Report: Medicare Pays Too Much for Some New Generics
WSJ Online
Thursday, August 28, 2008 - 8:09am
tags:
Pfizer Is Worth Another Look
Seeking Alpha
Thursday, August 28, 2008 - 8:08am
tags:
Amgen to Stop Offering Discounts on Anemia Drug
New York Times, NY
Thursday, August 28, 2008 - 8:00am
tags:
CROs: The 'Big Pharma Effect'
Seeking Alpha
Thursday, August 28, 2008 - 7:58am
tags:
Amgen to discontinue discounts on anemia drug: report
Yahoo/Reuters
Thursday, August 28, 2008 - 6:33am
tags:
Boehringer Drugs Disappoint in Company-Sponsored Stroke Study
Bloomberg
Thursday, August 28, 2008 - 6:32am
tags:
UCB Cuts 2,000 Jobs to Spur Profit; Shares Decline
Bloomberg
Thursday, August 28, 2008 - 6:32am
tags:
Cell Genesys' Saving Grace
Forbes
Wednesday, August 27, 2008 - 10:30pm
tags:
Takeda's Velcade Found Better Than Standard Blood-Cancer Drug
Bloomberg
Wednesday, August 27, 2008 - 10:28pm
tags:
Efficacy Questions Still Dog Vytorin
Forbes
Wednesday, August 27, 2008 - 10:27pm
tags:
Rough Road Ahead For Byetta
Forbes
Wednesday, August 27, 2008 - 10:24pm
tags:
Vioxx settlement judge caps legal fees at 32 pct
Yahoo/AP
Wednesday, August 27, 2008 - 4:41pm
tags:
King Pharma a Hold, Pre-Acquisition
Yahoo/Zacks.com
Wednesday, August 27, 2008 - 4:26pm
tags:
Grim Reaper Hurts Cell Genesys
Forbes
Wednesday, August 27, 2008 - 4:25pm
tags:
Another Storm Brewing For Vytorin
Forbes
Wednesday, August 27, 2008 - 4:23pm
tags:
Amylin, Lilly: Another Case of a Panic Driven Sell-Off
Seeking Alpha
Wednesday, August 27, 2008 - 4:20pm
tags:
Bad News Byetta
Forbes
Wednesday, August 27, 2008 - 4:19pm
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)
Drug Channels
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)
Drug Channels
Bad Bar Graphs
In the Pipeline
PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating (rerun)
Drug Channels
Infant RSV Vaccination Trouble
In the Pipeline
The BioSecure Act Falters?
In the Pipeline
Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble? (rerun)
Drug Channels
Computational Care
In the Pipeline
The Rings Less Traveled
In the Pipeline

Latest Jobs

Virtual Biopharma Sales Specialist
Raleigh, North Carolina, 27601
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement - Santa Rosa, CA
Santa Rosa, California,
Otsuka
Portfolio Sales Specialist - North Dakota / South Dakota / Nebraska
Lincoln, Nebraska, 68511
ICU Medical
Bilingual Business Development Representative
Kennedy Space Center, Florida
Complete Care
Business Development Manager, Facial - Chevy Chase, MD
Chevy Chase, Maryland, 20815
AbbVie
Virtual Biopharma Sales Specialist
Dallas, Texas, 75215
Syneos Health/ inVentiv Health Commercial LLC
Regional Director, Central Baltimore, Maryland, United States
Baltimore, Maryland, 21276
TBWA\Chiat\Day
Account Executive
San Antonio, Texas, 78208
Elara Caring
Nobel Biocare Regional Manager - Mid Atlantic
Washington, District of Columbia, 20022
enVista
Senior Manager, Professional Affairs (Northeast)
Jersey City, New Jersey, 07390
Bausch + Lomb
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information